Search company, investor...

Predict your next investment

Venture Capital
vastvc.com

Investments

52

Portfolio Exits

14

Funds

13

About Vast Ventures

Vast Ventures is the angel investment vehicle for Doug Chertok. Vast Ventures is a seed fund and incubator focused on sustainable industries, innovation, and digital media and marketing companies.

Headquarters Location

20 Butternut Drive

Pearl River, New York, 10965,

United States

917-215-5214

Want to inform investors similar to Vast Ventures about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing Vast Ventures

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Vast Ventures in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Latest Vast Ventures News

PatchRx Raises $8M in Funding

Aug 30, 2023

PatchRx , a Tulsa, OK-based medication management startup, raised $8M in funding. The round, which brought the total amount to $15M, was led by Atento Capital, with participation from Vast Ventures, Cortado Ventures, Forum Ventures, and Plains VC. The company intends to use the funds to expand operations and its business reach. Co-founded in 2018 by Andrew Aertker and Gavin Buchanan, PatchRx is a patient-focused medication management platform improving outcomes through connected technologies. It provides personalized support through a service that combines a patented universal smart pill bottle device with a provider web app and on-staff nurses. The patented technology has been deployed in over 40 clinics across the US from Alaska to New Jersey. In 2022, the company started offering a medication adherence platform under new Medicare RTM billing codes, creating an opportunity to engage various stakeholders of healthcare simultaneously. PatchRx is on track to also deploy its technology beyond pain management, in clinical trials, and in psychiatric markets. The company has experienced an accelerated period of growth in which they expanded from a team of 10 to 80+ employees and reached $4m in revenue in 12 months. FinSMEs

Vast Ventures Investments

52 Investments

Vast Ventures has made 52 investments. Their latest investment was in PatchRx as part of their Series B on August 8, 2023.

CBI Logo

Vast Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/29/2023

Series B

PatchRx

$8M

Yes

2

8/25/2023

Pre-Seed

Base

$0.5M

Yes

Dhuna Ventures, Treble Capital, Undisclosed Angel Investors, and Vast Ventures

1

3/29/2023

Seed VC

Florence

$20M

Yes

6

12/8/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

6/29/2022

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/29/2023

8/25/2023

3/29/2023

12/8/2022

6/29/2022

Round

Series B

Pre-Seed

Seed VC

Series A

Seed VC

Company

PatchRx

Base

Florence

Subscribe to see more

Subscribe to see more

Amount

$8M

$0.5M

$20M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Dhuna Ventures, Treble Capital, Undisclosed Angel Investors, and Vast Ventures

Sources

2

1

6

10

10

Vast Ventures Portfolio Exits

14 Portfolio Exits

Vast Ventures has 14 portfolio exits. Their latest portfolio exit was Ophelos on September 20, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/20/2023

Acquired

$99M

2

5/10/2022

Acquired

$99M

4

9/17/2021

Reverse Merger

$99M

10

6/1/2021

Reverse Merger

Subscribe to see more

$99M

Subscribe to see more

10

12/17/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/20/2023

5/10/2022

9/17/2021

6/1/2021

12/17/2019

Exit

Acquired

Acquired

Reverse Merger

Reverse Merger

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

2

4

10

10

10

Vast Ventures Fund History

13 Fund Histories

Vast Ventures has 13 funds, including Vast Ventures-Studio SC.

Closing Date

Fund

Fund Type

Status

Amount

Sources

10/19/2020

Vast Ventures-Studio SC

$3.54M

1

2/22/2019

Vast Ventures Transit III

Early-Stage Venture Capital

Closed

$0.16M

1

2/20/2019

Vast Ventures TimeMachine II

Early-Stage Venture Capital

Closed

$10M

1

10/3/2017

Vast Ventures Phosphorus

$99M

10

4/19/2017

Vast Ventures Transit II

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

10/19/2020

2/22/2019

2/20/2019

10/3/2017

4/19/2017

Fund

Vast Ventures-Studio SC

Vast Ventures Transit III

Vast Ventures TimeMachine II

Vast Ventures Phosphorus

Vast Ventures Transit II

Fund Type

Early-Stage Venture Capital

Early-Stage Venture Capital

Subscribe to see more

Status

Closed

Closed

Subscribe to see more

Amount

$3.54M

$0.16M

$10M

$99M

$99M

Sources

1

1

1

10

10

Vast Ventures Team

2 Team Members

Vast Ventures has 2 team members, including current Founder, General Partner, Doug Chertok.

Name

Work History

Title

Status

Doug Chertok

Founder, General Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Doug Chertok

Subscribe to see more

Work History

Title

Founder, General Partner

Subscribe to see more

Status

Current

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.